Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors

Author:

Bhatt Rikesh1ORCID,van den Hout Ardo2,Antoniou Antonis C.3,Shah Mitul4,Ficorella Lorenzo3,Steggall Emily5,Easton Douglas F.3,Pharoah Paul D. P.36,Pashayan Nora1ORCID

Affiliation:

1. Department of Applied Health Research University College London London UK

2. Department of Statistical Science University College London London UK

3. Department of Public Health and Primary Care University of Cambridge Cambridge UK

4. Department of Oncology University of Cambridge Cambridge UK

5. School of Medicine Cardiff University Cardiff UK

6. Department of Computational Biomedicine Cedars Sinai Medical Center Los Angeles California USA

Abstract

AbstractBackgroundGenetic, lifestyle, reproductive, and anthropometric factors are associated with the risk of developing breast cancer. However, it is not yet known whether polygenic risk score (PRS) and absolute risk based on a combination of risk factors are associated with the risk of progression of breast cancer. This study aims to estimate the distribution of sojourn time (pre‐clinical screen‐detectable period) and mammographic sensitivity by absolute breast cancer risk derived from polygenic profile and the other risk factors.MethodsThe authors used data from a population‐based case‐control study. Six categories of 10‐year absolute risk based on different combinations of risk factors were derived using the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm. Women were classified into low, medium, and high‐risk groups. The authors constructed a continuous‐time multistate model. To calculate the sojourn time, they simulated the trajectories of subjects through the disease states.ResultsThere was little difference in sojourn time with a large overlap in the 95% confidence interval (CI) between the risk groups across the six risk categories and PRS studied. However, the age of entry into the screen‐detectable state varied by risk category, with the mean age of entry of 53.4 years (95% CI, 52.2–54.1) and 57.0 years (95% CI, 55.1–57.7) in the high‐risk and low‐risk women, respectively.ConclusionIn risk‐stratified breast screening, the age at the start of screening, but not necessarily the frequency of screening, should be tailored to a woman’s risk level. The optimal risk‐stratified screening strategy that would improve the benefit‐to‐harm balance and the cost‐effectiveness of the screening programs needs to be studied.

Funder

Wellcome Trust

National Institutes of Health

NIHR Cambridge Biomedical Research Centre

Cancer Research UK

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. The benefits and harms of breast cancer screening: an independent review

2. Breast Cancer Now.Facts and statistics 2023;2023. Accessed September 13 2023.https://breastcancernow.org/about‐us/media/facts‐%20statistics

3. Cancer Research UK.Cancer statistics explained;2023.Accessed September 21 2023.https://www.cancerresearchuk.org/health‐professional/cancer‐statistics/cancer‐stats‐explained

4. Public Health England.Breast screening: reporting classification and monitoring of interval cancers and cancers following previous assessment;2021. Accessed September 21 2023.https://www.gov.uk/government/publications/breast‐screening‐interval‐cancers/breast‐screening‐reporting‐classification‐and‐monitoring‐of‐interval‐cancers‐and‐cancers‐following‐previous‐assessment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3